Hematologic Cancers

PET Imaging After ASCT Identified Residual Disease in MM

By

Andrea S. Blevins Primeau, PhD, MBA

Publish Date September 27, 2023

Researchers sought to determine whether screening patients with MM after ASCT with FDG-PET would be able to identify patients with residual disease.

Postoperative Complications Common After Spinal Surgery for Multiple Myeloma

By

Jessica Nye, PhD

Publish Date September 26, 2023

Researchers evaluated data from 270 patients with MM undergoing spine surgery to determine complication and reoperation rates.

Vitamins C, D Supplementation Beneficial in Chemotherapy for Acute Myeloid Leukemia

By

Jennifer Larson

Publish Date September 22, 2023

Use of vitamin C and D supplementation evaluated for its efficacy for patients with AML undergoing intensive induction chemotherapy.

Aphexda Approved for Stem Cell Mobilization for ASCT in Multiple Myeloma

By

Brian Park, PharmD

Publish Date September 19, 2023

Aphexda is expected to be available in September 2023.

Global Incidence of Early-Onset Cancers Rose 80% From 1990 to 2019

By

Jen Smith

Publish Date September 14, 2023

New data suggest that, from 1990 to 2019, the global incidence of early-onset cancer increased by nearly 80%, and the rate of early-onset cancer deaths increased by nearly 30%.